Oligonucleotide Synthesis Market Primed to Reach USD USD 10.17 Billion, With Growth Accelerating at 12.55% Annually by 2032 | Bio-Synthesis Inc.,Biosearch Technologies, Eurofins Genomics

𝐀𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡'𝐬 𝐬𝐭𝐮𝐝𝐲, 𝐭𝐡𝐞 𝐨𝐥𝐢𝐠𝐨𝐧𝐮𝐜𝐥𝐞𝐨𝐭𝐢𝐝𝐞 𝐬𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟐.𝟓𝟓% 𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐩𝐞𝐫𝐢𝐨𝐝. 𝐓𝐡𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐯𝐚𝐥𝐮𝐞 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 𝟑.𝟓𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐭𝐨 𝐔𝐒𝐃 𝟏𝟎.𝟏𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟑𝟐.

The industry's growth is being fuelled by the expanding usage of synthesized oligos in applications, including clinical and molecular diagnostics. Also, the market for oligonucleotide synthesis is expanding due to governments across contrasting regions massively funding research and development in sectors involving pharmaceutical and biotechnology.

𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐆𝐞𝐭 𝐀 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/oligonucleotide-synthesis-market/request-for-sample

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

Oligonucleotides are compact solitary or twin-looped segments of nucleic acid that are connected to configure solitary chain biological polymers. The discrete nucleotide bases can be considered identical to monomers that fabricate classical chemical polymers. A nucleotide comprises three parts: a nitrogen-accommodating base, a sugar molecule with five carbons, and an additional phosphate group. On the other hand, nucleotides comprise nonorganic and nonapproved bases. Customary instances involve LNA, Morpholino, and structurally adjusted bases or backbones.

𝐌𝐚𝐣𝐨𝐫 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

The market is splintered and is expected to observe contention due to many players existence. Key companies in the oligonucleotide synthesis market are mentioned below:
• Agilent Technologies
• ATDBio Ltd.
• Bio-Synthesis Inc.
• Biosearch Technologies
• Eurofins Genomics
• GE Healthcare
• Genewiz
• GenScript Corporation
• Integrated DNA Technologies (IDT)
• LGC Biosearch Technologies
• Merck KGaA (including Sigma-Aldrich)
• Nitto Denko Avecia Inc.
• Thermo Fisher Scientific
• TriLink BioTechnologies
• Twist Bioscience

𝐂𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐁𝐞𝐥𝐨𝐰 𝐋𝐢𝐧𝐤 𝐭𝐨 𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/buy/3883/2

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬

• Technological Advancements: Innovations in synthesis technologies, such as automated synthesizers and high-throughput methods, have significantly reduced the cost and time required for oligonucleotide synthesis, driving market growth.
• Increasing Research Activities: The rising volume of genetic research and genomics projects, including the Human Genome Project and various CRISPR-based research, has spurred demand for oligonucleotides.
• Expanding Therapeutic Applications: Oligonucleotides are being increasingly used in therapeutic applications, such as antisense oligonucleotides, siRNA, and miRNA therapies, which target genetic disorders and cancers.
• Personalized Medicine: The shift towards personalized medicine, where treatments are tailored to the individual's genetic makeup, has increased the demand for custom oligonucleotide synthesis.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/oligonucleotide-synthesis-market/request-for-sample

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭

The research shows that the oligonucleotide synthesis market analysis is primarily segmented by product, application, and region. According to the product analysis, the synthesized oligonucleotide products segment held the largest market share. This surge is credited to the escalated generality of genomic studies involving gene expression investigation and genetic testing.

Furthermore, according to application analysis, the PCR primer segment accounted for the highest share. The escalating acquisition of primers in gene sequencing observation is outstanding, pushed by their usefulness in fluorescent discernment and earmarked amplification, which causes varied primer outlines presenting several probes and primer-dependent perception chemistries.

𝐎𝐥𝐢𝐠𝐨𝐧𝐮𝐜𝐥𝐞𝐨𝐭𝐢𝐝𝐞 𝐒𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• In 2023, the synthesized oligonucleotide products segment is expected to witness highest growth during forecast period owing to increased prevalence of genomic studies
• PCR primers segment is expected to dominate the oligonucleotide synthesis market during forecast period. This is attributed to increase in detecting and measuring gene expression
• In 2023, North America accounted for the largest revenue share due to presence of major players, technological advancements, and growing awareness of genetic disorders.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐖𝐢𝐝𝐞-𝐫𝐚𝐧𝐠𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐟 𝐏𝐌𝐑'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

𝐂𝐚𝐧𝐜𝐞𝐫 𝐈𝐦𝐦𝐮𝐧𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/cancer-immunotherapy-market

𝐁𝐥𝐨𝐜𝐤𝐜𝐡𝐚𝐢𝐧 𝐈𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/blockchain-in-healthcare

𝐑𝐞𝐯𝐞𝐧𝐮𝐞 𝐂𝐲𝐜𝐥𝐞 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/revenue-cycle-management-market

𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.